KeyMed Biosciences Inc
HKEX:2162
Intrinsic Value
The intrinsic value of one KeyMed Biosciences Inc stock under the Base Case scenario is hidden HKD. Compared to the current market price of 57.5 HKD, KeyMed Biosciences Inc is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
KeyMed Biosciences Inc
KeyMed Biosciences Inc looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if KeyMed Biosciences Inc is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Fundamental Analysis

Revenue & Expenses Breakdown
KeyMed Biosciences Inc
Balance Sheet Decomposition
KeyMed Biosciences Inc
Current Assets | 2.5B |
Cash & Short-Term Investments | 2.2B |
Receivables | 69.5m |
Other Current Assets | 240.9m |
Non-Current Assets | 1.3B |
Long-Term Investments | 210m |
PP&E | 1.1B |
Intangibles | 9.7m |
Other Non-Current Assets | 5.4m |
Free Cash Flow Analysis
KeyMed Biosciences Inc
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
KeyMed Biosciences Inc
Revenue
|
428.1m
CNY
|
Cost of Revenue
|
-12.2m
CNY
|
Gross Profit
|
415.9m
CNY
|
Operating Expenses
|
-1B
CNY
|
Operating Income
|
-591.5m
CNY
|
Other Expenses
|
76.2m
CNY
|
Net Income
|
-515.2m
CNY
|
Profitability Score
Profitability Due Diligence
KeyMed Biosciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
KeyMed Biosciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
KeyMed Biosciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
KeyMed Biosciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
KeyMed Biosciences Inc
According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 61.17 HKD with a low forecast of 55.55 HKD and a high forecast of 74.29 HKD.
Dividends
Current shareholder yield for KeyMed Biosciences Inc is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one KeyMed Biosciences Inc stock under the Base Case scenario is hidden HKD.
Compared to the current market price of 57.5 HKD, KeyMed Biosciences Inc is hidden .